Advancement of modular therapies offers a new dynamic for today’s patients, but there’s still a need to maintain infection ...

Approval is Another Milestone of Viatris' Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy ...

Most long-COVID care in B.C. is currently delivered through large online group telehealth sessions from the Bowen ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

Scientists believe they've discovered a potential long COVID biomarker that would be the first “quantifiable indicator” of ...

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

Chikungunya is not just a viral fever, but it can become a disease that leaves a long-term effect on the body. Severe joint ...

"I lost over a decade of my life to this, but I'm getting it back and I hope my story helps others do the same," Laura ...

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...

The genetic signals are associated with the immune system and nervous system, matching symptoms patients report.

The Johns Hopkins University spinout's MycoMeia Aspergillus Assay is used to aid the diagnosis of the lung disease aspergillosis in immunocompromised patients.